Mach7 Technologies (M7T) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
24 Dec, 2025Executive summary
Revenue grew 33% year-over-year to $17.74 million for the first half, driven by subscription and capital software licence sales, with positive adjusted EBITDA and NPATA, and a focus on recurring revenue and cost discipline.
Net loss after tax narrowed to $1.87 million from $4.63 million in the prior period, reflecting improved operating leverage.
Strategic realignment of the sales team to focus on net new customer acquisition and customer success, aiming for three to four new logos by year-end.
Completed investment in three strategic pillars: cloud enablement, supportability, and interoperability, with ongoing cost optimization initiatives.
Maintained a strong financial position with no debt and initiated an on-market share buy-back program.
Financial highlights
Revenue for the first half was $17.74 million, up 33% year-over-year; recurring revenue reached $12.65 million, covering 80% of operating expenses.
CARR grew 19% to $31.8 million; ARR at $25.1 million, both covering about 80% of OpEx.
Adjusted EBITDA was $0.81 million, up from a loss of $1.58 million year-over-year; adjusted NPATA was $1.4 million.
Operating expenses were $15.81 million, up 15% year-over-year due to targeted investments.
Cash on hand at period end was $23.6 million, increasing to $25.3 million by end of January, with no debt.
Outlook and guidance
Reaffirmed FY2025 guidance for 15–25% growth in CARR and revenue, with OpEx growth below revenue growth.
Sales pipeline remains robust and diverse across regions, care settings, and product lines.
Targeting three to four net new customer wins by year-end and expecting professional services revenue to rebound in the second half.
Anticipate further OpEx savings in FY2026 as internal 3D engine project eliminates royalty fees.
Latest events from Mach7 Technologies
- Revenue down 23% with strong margins; cost controls and Flamingo set stage for FY27 growth.M7T
H1 202627 Feb 2026 - Stable ARR, positive cash flow, and new product traction support a confident outlook.M7T
Q2 20263 Feb 2026 - Sales orders up 52%, recurring revenue and cash at record highs, subscription growth strong.M7T
Q4 2024 TU2 Feb 2026 - Record recurring revenue and sales orders drive positive cash flow amid subscription transition.M7T
H2 202423 Jan 2026 - CARR and ARR rose in Q1 FY25, with strong cash reserves and reaffirmed growth guidance.M7T
Q1 2025 TU17 Jan 2026 - Record sales and recurring revenue growth support a scalable, innovation-driven outlook for FY25.M7T
AGM 202412 Jan 2026 - Recurring revenue up 15.6%, strong cash, and FY25 growth guidance reaffirmed.M7T
Q2 2025 TU9 Jan 2026 - Q3 saw strong cash flow, 28% higher cash receipts, and reaffirmed double-digit growth guidance.M7T
Q3 202527 Dec 2025 - Solid FY 2025 results, leadership renewal, and AI-focused strategy set stage for global growth.M7T
AGM 202528 Nov 2025